Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
24
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Duty Stuart | Director | 4 | $0 | $0 | 2026-06-10 |
| Wills Robert James | Director | 11 | $74.0K | $0 | 2026-06-10 |
| Saik Andrew | Director | 4 | $0 | $0 | 2026-06-10 |
| Fischer Seth H. Z. | Director | 5 | $0 | $0 | 2026-06-10 |
| TOMSICEK MICHAEL JOHN | Director | 8 | $79.8K | $0 | 2026-06-10 |
| Giles Lisa M. | Director | 7 | $0 | $0 | 2026-06-10 |
| PAPA JOSEPH C | Director | 6 | $0 | $0 | 2026-06-10 |
| Oliveto Joseph | President and CEO | 24 | $0 | $555.7K | 2026-04-16 |
| Nelson Jeffrey Edward | Chief Operating Officer | 12 | $0 | $158.2K | 2026-02-02 |
| Bharucha David | Chief Medical Officer | 18 | $47.4K | $158.2K | 2026-02-02 |
| Hasija Amit | CFO & EVP of Corp. Development | 20 | $0 | $158.2K | 2026-02-02 |
| Muller Lorenz | Chief Commercial Officer | 28 | $0 | $145.9K | 2026-02-02 |
| Liebert Debra K. | Director | 11 | $73.9K | $0 | 2025-07-11 |
| Pasternak Richard C | Director | 6 | $52.0K | $0 | 2023-06-07 |
| WONG RODERICK | 10% Owner | 5 | $4.48M | $0 | 2023-03-22 |
| RTW INVESTMENTS, LP | 10% Owner | 18 | $66.98M | $13.56M | 2022-09-07 |
| TRUEX PAUL F | Director | 12 | $28.0K | $0 | 2022-05-31 |
| Plat Francis | Chief Medical Officer | 3 | $0 | $0 | 2021-03-24 |
| FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC | 10% Owner | 13 | $6.50M | $4.32M | 2020-07-29 |
| Edick Paul R | Director | 1 | $0 | $0 | 2020-06-05 |
| Novo Holdings A/S | 10% Owner | 6 | $5.00M | $3.84M | 2019-11-25 |
| Maness Timothy | Vice President, Finance | 2 | $0 | $0 | 2019-09-09 |
| Douville Philippe | Chief Scientific Officer | 2 | $0 | $0 | 2019-05-13 |
| BDC CAPITAL INC. | 10% Owner | 1 | $3.00M | $0 | 2019-05-08 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Wills Robert James | Director | A Award deriv | 2026-06-10 | 2026-06-12 | 77,000 | — | $0 | 77,000 | SEC↗ |
| Duty Stuart | Director | A Award deriv | 2026-06-10 | 2026-06-12 | 77,000 | — | $0 | 77,000 | SEC↗ |
| Fischer Seth H. Z. | Director | A Award deriv | 2026-06-10 | 2026-06-12 | 77,000 | — | $0 | 77,000 | SEC↗ |
| Giles Lisa M. | Director | A Award deriv | 2026-06-10 | 2026-06-12 | 77,000 | — | $0 | 77,000 | SEC↗ |
| PAPA JOSEPH C | Director | A Award deriv | 2026-06-10 | 2026-06-12 | 77,000 | — | $0 | 77,000 | SEC↗ |
| Saik Andrew | Director | A Award deriv | 2026-06-10 | 2026-06-12 | 77,000 | — | $0 | 77,000 | SEC↗ |
| TOMSICEK MICHAEL JOHN | Director | A Award deriv | 2026-06-10 | 2026-06-12 | 77,000 | — | $0 | 77,000 | SEC↗ |
| Oliveto Joseph | President and CEO | S Sale | 2026-04-16 | 2026-04-20 | 36,500 | $2.26 | $82.5K | 446,244 | SEC↗ |
| Oliveto Joseph | President and CEO | A Award deriv | 2026-02-02 | 2026-02-04 | 453,000 | — | $0 | 453,000 | SEC↗ |
| Oliveto Joseph | President and CEO | A Award deriv | 2026-02-02 | 2026-02-04 | 679,000 | — | $0 | 679,000 | SEC↗ |
| Bharucha David | Chief Medical Officer | A Award deriv | 2026-02-02 | 2026-02-04 | 204,000 | — | $0 | 204,000 | SEC↗ |
| Bharucha David | Chief Medical Officer | A Award deriv | 2026-02-02 | 2026-02-04 | 136,000 | — | $0 | 136,000 | SEC↗ |
| Nelson Jeffrey Edward | Chief Operating Officer | A Award deriv | 2026-02-02 | 2026-02-04 | 204,000 | — | $0 | 204,000 | SEC↗ |
| Nelson Jeffrey Edward | Chief Operating Officer | A Award deriv | 2026-02-02 | 2026-02-04 | 136,000 | — | $0 | 136,000 | SEC↗ |
| Hasija Amit | CFO & EVP of Corp. Developme | A Award deriv | 2026-02-02 | 2026-02-04 | 204,000 | — | $0 | 204,000 | SEC↗ |
| Hasija Amit | CFO & EVP of Corp. Developme | A Award deriv | 2026-02-02 | 2026-02-04 | 136,000 | — | $0 | 136,000 | SEC↗ |
| Muller Lorenz | Chief Commercial Officer | A Award deriv | 2026-02-02 | 2026-02-04 | 136,000 | — | $0 | 136,000 | SEC↗ |
| Muller Lorenz | Chief Commercial Officer | A Award deriv | 2026-02-02 | 2026-02-04 | 204,000 | — | $0 | 204,000 | SEC↗ |
| Hasija Amit | CFO & EVP of Corp. Developme | A Award deriv | 2026-02-02 | 2026-02-05 | 204,000 | — | $0 | 204,000 | SEC↗ |
| Muller Lorenz | Chief Commercial Officer | A Award deriv | 2026-02-02 | 2026-02-05 | 204,000 | — | $0 | 204,000 | SEC↗ |
| Nelson Jeffrey Edward | Chief Operating Officer | A Award deriv | 2026-02-02 | 2026-02-05 | 204,000 | — | $0 | 204,000 | SEC↗ |
| Bharucha David | Chief Medical Officer | A Award deriv | 2026-02-02 | 2026-02-05 | 204,000 | — | $0 | 204,000 | SEC↗ |
| Oliveto Joseph | President and CEO | A Award deriv | 2026-02-02 | 2026-02-05 | 679,000 | — | $0 | 679,000 | SEC↗ |
| Oliveto Joseph | President and CEO | M Exercise deriv | 2026-01-26 | 2026-01-28 | 66,600 | — | $0 | 199,800 | SEC↗ |
| Hasija Amit | CFO & EVP of Corp. Developme | M Exercise deriv | 2026-01-26 | 2026-01-28 | 20,100 | — | $0 | 60,300 | SEC↗ |
| Muller Lorenz | Chief Commercial Officer | M Exercise deriv | 2026-01-26 | 2026-01-28 | 20,100 | — | $0 | 60,300 | SEC↗ |
| Nelson Jeffrey Edward | Chief Operating Officer | M Exercise deriv | 2026-01-26 | 2026-01-28 | 20,100 | — | $0 | 60,300 | SEC↗ |
| Bharucha David | Chief Medical Officer | M Exercise deriv | 2026-01-26 | 2026-01-28 | 20,100 | — | $0 | 60,300 | SEC↗ |
| Oliveto Joseph | President and CEO | M Exercise | 2026-01-26 | 2026-01-28 | 66,600 | — | $0 | 517,267 | SEC↗ |
| Oliveto Joseph | President and CEO | S Sale | 2026-01-26 | 2026-01-28 | 34,523 | $1.93 | $66.6K | 482,744 | SEC↗ |
| Hasija Amit | CFO & EVP of Corp. Developme | M Exercise | 2026-01-26 | 2026-01-28 | 20,100 | — | $0 | 112,093 | SEC↗ |
| Hasija Amit | CFO & EVP of Corp. Developme | S Sale | 2026-01-26 | 2026-01-28 | 12,245 | $1.93 | $23.6K | 99,848 | SEC↗ |
| Muller Lorenz | Chief Commercial Officer | S Sale | 2026-01-26 | 2026-01-28 | 11,180 | $1.93 | $21.6K | 205,406 | SEC↗ |
| Muller Lorenz | Chief Commercial Officer | M Exercise | 2026-01-26 | 2026-01-28 | 20,100 | — | $0 | 216,586 | SEC↗ |
| Nelson Jeffrey Edward | Chief Operating Officer | S Sale | 2026-01-26 | 2026-01-28 | 12,245 | $1.93 | $23.6K | 49,848 | SEC↗ |
| Nelson Jeffrey Edward | Chief Operating Officer | M Exercise | 2026-01-26 | 2026-01-28 | 20,100 | — | $0 | 62,093 | SEC↗ |
| Bharucha David | Chief Medical Officer | M Exercise | 2026-01-26 | 2026-01-28 | 20,100 | — | $0 | 125,426 | SEC↗ |
| Bharucha David | Chief Medical Officer | S Sale | 2026-01-26 | 2026-01-28 | 12,245 | $1.93 | $23.6K | 113,181 | SEC↗ |
| Oliveto Joseph | President and CEO | S Sale | 2026-01-08 | 2026-01-09 | 43,000 | $2.25 | $96.8K | 303,721 | SEC↗ |
| Oliveto Joseph | President and CEO | S Sale | 2026-01-07 | 2026-01-09 | 500 | $2.25 | $1.1K | 346,721 | SEC↗ |
| Oliveto Joseph | President and CEO | S Sale | 2025-12-15 | 2026-01-28 | 133,054 | $2.32 | $308.7K | 450,667 | SEC↗ |
| Hasija Amit | CFO & EVP of Corp. Developme | S Sale | 2025-12-15 | 2026-01-28 | 58,007 | $2.32 | $134.6K | 91,993 | SEC↗ |
| Muller Lorenz | Chief Commercial Officer | S Sale | 2025-12-15 | 2026-01-28 | 53,566 | $2.32 | $124.3K | 196,486 | SEC↗ |
| Nelson Jeffrey Edward | Chief Operating Officer | S Sale | 2025-12-15 | 2026-01-28 | 58,007 | $2.32 | $134.6K | 41,993 | SEC↗ |
| Bharucha David | Chief Medical Officer | S Sale | 2025-12-15 | 2026-01-28 | 58,007 | $2.32 | $134.6K | 105,326 | SEC↗ |
| Oliveto Joseph | President and CEO | A Award deriv | 2025-12-12 | 2026-01-28 | 280,000 | — | $0 | 280,000 | SEC↗ |
| Hasija Amit | CFO & EVP of Corp. Developme | A Award deriv | 2025-12-12 | 2026-01-28 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Muller Lorenz | Chief Commercial Officer | A Award deriv | 2025-12-12 | 2026-01-28 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Nelson Jeffrey Edward | Chief Operating Officer | A Award deriv | 2025-12-12 | 2026-01-28 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Bharucha David | Chief Medical Officer | A Award deriv | 2025-12-12 | 2026-01-28 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Oliveto Joseph | President and CEO | A Award | 2025-12-12 | 2026-01-28 | 280,000 | — | $0 | 583,721 | SEC↗ |
| Hasija Amit | CFO & EVP of Corp. Developme | A Award | 2025-12-12 | 2026-01-28 | 100,000 | — | $0 | 150,000 | SEC↗ |
| Muller Lorenz | Chief Commercial Officer | A Award | 2025-12-12 | 2026-01-28 | 100,000 | — | $0 | 250,052 | SEC↗ |
| Nelson Jeffrey Edward | Chief Operating Officer | A Award | 2025-12-12 | 2026-01-28 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Bharucha David | Chief Medical Officer | A Award | 2025-12-12 | 2026-01-28 | 100,000 | — | $0 | 163,333 | SEC↗ |
| Muller Lorenz | Chief Commercial Officer | G Gift | 2025-12-09 | 2025-12-11 | 25,000 | — | $0 | 150,052 | SEC↗ |
| PAPA JOSEPH C | Director | A Award deriv | 2025-07-11 | 2025-07-15 | 100,000 | — | $0 | 100,000 | SEC↗ |
| PAPA JOSEPH C | Director | A Award deriv | 2025-07-11 | 2025-07-15 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Muller Lorenz | Chief Commercial Officer | A Award deriv | 2025-07-11 | 2025-07-15 | 66,666 | — | $0 | 66,666 | SEC↗ |
| Muller Lorenz | Chief Commercial Officer | A Award deriv | 2025-07-11 | 2025-07-15 | 66,666 | — | $0 | 66,666 | SEC↗ |
| Oliveto Joseph | President and CEO | A Award deriv | 2025-07-11 | 2025-07-15 | 66,666 | — | $0 | 66,666 | SEC↗ |
| Oliveto Joseph | President and CEO | A Award deriv | 2025-07-11 | 2025-07-15 | 66,666 | — | $0 | 66,666 | SEC↗ |
| Bharucha David | Chief Medical Officer | A Award deriv | 2025-07-11 | 2025-07-15 | 53,333 | — | $0 | 53,333 | SEC↗ |
| Bharucha David | Chief Medical Officer | A Award deriv | 2025-07-11 | 2025-07-15 | 53,333 | — | $0 | 53,333 | SEC↗ |
| Wills Robert James | Director | A Award deriv | 2025-07-11 | 2025-07-15 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Wills Robert James | Director | A Award deriv | 2025-07-11 | 2025-07-15 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Hasija Amit | CFO & EVP of Corp. Developme | A Award deriv | 2025-07-11 | 2025-07-15 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Hasija Amit | CFO & EVP of Corp. Developme | A Award deriv | 2025-07-11 | 2025-07-15 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Liebert Debra K. | Director | A Award deriv | 2025-07-11 | 2025-07-15 | 16,793 | — | $0 | 16,793 | SEC↗ |
| Liebert Debra K. | Director | A Award deriv | 2025-07-11 | 2025-07-15 | 16,793 | — | $0 | 16,793 | SEC↗ |
| PAPA JOSEPH C | Director | A Award | 2025-07-11 | 2025-07-15 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Muller Lorenz | Chief Commercial Officer | A Award | 2025-07-11 | 2025-07-15 | 66,666 | — | $0 | 175,052 | SEC↗ |
| Oliveto Joseph | President and CEO | A Award | 2025-07-11 | 2025-07-15 | 66,666 | — | $0 | 347,221 | SEC↗ |
| Bharucha David | Chief Medical Officer | A Award | 2025-07-11 | 2025-07-15 | 53,333 | — | $0 | 63,333 | SEC↗ |
| Wills Robert James | Director | A Award | 2025-07-11 | 2025-07-15 | 50,000 | — | $0 | 65,000 | SEC↗ |
| Hasija Amit | CFO & EVP of Corp. Developme | A Award | 2025-07-11 | 2025-07-15 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Liebert Debra K. | Director | A Award | 2025-07-11 | 2025-07-15 | 16,666 | — | $0 | 16,793 | SEC↗ |
| Duty Stuart | Director | A Award deriv | 2025-06-10 | 2025-06-12 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Fischer Seth H. Z. | Director | A Award deriv | 2025-06-10 | 2025-06-12 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Giles Lisa M. | Director | A Award deriv | 2025-06-10 | 2025-06-12 | 40,000 | — | $0 | 40,000 | SEC↗ |
| PAPA JOSEPH C | Director | A Award deriv | 2025-06-10 | 2025-06-12 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Saik Andrew | Director | A Award deriv | 2025-06-10 | 2025-06-12 | 40,000 | — | $0 | 40,000 | SEC↗ |
| TOMSICEK MICHAEL JOHN | Director | A Award deriv | 2025-06-10 | 2025-06-12 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Wills Robert James | Director | A Award deriv | 2025-06-10 | 2025-06-12 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Oliveto Joseph | President and CEO | A Award deriv | 2025-01-27 | 2025-01-29 | 266,400 | — | $0 | 266,400 | SEC↗ |
| Oliveto Joseph | President and CEO | A Award deriv | 2025-01-27 | 2025-01-29 | 399,600 | — | $0 | 399,600 | SEC↗ |
| Bharucha David | Chief Medical Officer | A Award deriv | 2025-01-27 | 2025-01-29 | 120,600 | — | $0 | 120,600 | SEC↗ |
| Bharucha David | Chief Medical Officer | A Award deriv | 2025-01-27 | 2025-01-29 | 80,400 | — | $0 | 80,400 | SEC↗ |
| Hasija Amit | CFO & EVP of Corp. Developme | A Award deriv | 2025-01-27 | 2025-01-29 | 120,600 | — | $0 | 120,600 | SEC↗ |
| Hasija Amit | CFO & EVP of Corp. Developme | A Award deriv | 2025-01-27 | 2025-01-29 | 80,400 | — | $0 | 80,400 | SEC↗ |
| Muller Lorenz | Chief Commercial Officer | A Award deriv | 2025-01-27 | 2025-01-29 | 80,400 | — | $0 | 80,400 | SEC↗ |
| Muller Lorenz | Chief Commercial Officer | A Award deriv | 2025-01-27 | 2025-01-29 | 120,600 | — | $0 | 120,600 | SEC↗ |
| Nelson Jeffrey Edward | Chief Operating Officer | A Award deriv | 2025-01-27 | 2025-01-29 | 120,600 | — | $0 | 120,600 | SEC↗ |
| Nelson Jeffrey Edward | Chief Operating Officer | A Award deriv | 2025-01-27 | 2025-01-29 | 80,400 | — | $0 | 80,400 | SEC↗ |
| PAPA JOSEPH C | Director | A Award deriv | 2024-09-03 | 2024-09-05 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Wills Robert James | Director | A Award deriv | 2024-08-28 | 2024-08-29 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Fischer Seth H. Z. | Director | A Award deriv | 2024-08-28 | 2024-08-29 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Giles Lisa M. | Director | A Award deriv | 2024-08-28 | 2024-08-29 | 40,000 | — | $0 | 40,000 | SEC↗ |
| TOMSICEK MICHAEL JOHN | Director | A Award deriv | 2024-08-28 | 2024-08-29 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Duty Stuart | Director | A Award deriv | 2024-08-28 | 2024-08-29 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Saik Andrew | Director | A Award deriv | 2024-08-28 | 2024-08-29 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Duty Stuart | Director | A Award deriv | 2024-07-15 | 2024-07-17 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Saik Andrew | Director | A Award deriv | 2024-07-15 | 2024-07-17 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Fischer Seth H. Z. | Director | A Award deriv | 2023-06-07 | 2023-06-09 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Giles Lisa M. | Director | A Award deriv | 2023-06-07 | 2023-06-09 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Liebert Debra K. | Director | A Award deriv | 2023-06-07 | 2023-06-09 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Pasternak Richard C | Director | A Award deriv | 2023-06-07 | 2023-06-09 | 30,000 | — | $0 | 30,000 | SEC↗ |
| TOMSICEK MICHAEL JOHN | Director | A Award deriv | 2023-06-07 | 2023-06-09 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Wills Robert James | Director | A Award deriv | 2023-06-07 | 2023-06-09 | 30,000 | — | $0 | 30,000 | SEC↗ |
| WONG RODERICK | 10% Owner | J Other | 2023-03-22 | 2023-03-24 | 1,059,000 | — | $0 | 3,256,102 | SEC↗ |
| Fischer Seth H. Z. | Director | A Award deriv | 2023-03-21 | 2023-03-23 | 42,000 | — | $0 | 42,000 | SEC↗ |
| Oliveto Joseph | President and CEO | A Award deriv | 2023-02-16 | 2023-02-17 | 360,000 | — | $0 | 360,000 | SEC↗ |
| Bharucha David | Chief Medical Officer | A Award deriv | 2023-02-16 | 2023-02-17 | 185,000 | — | $0 | 185,000 | SEC↗ |
| Hasija Amit | CFO & EVP of Corp. Developme | A Award deriv | 2023-02-16 | 2023-02-17 | 130,000 | — | $0 | 130,000 | SEC↗ |
| Nelson Jeffrey Edward | Chief Operating Officer | A Award deriv | 2023-02-16 | 2023-02-17 | 105,000 | — | $0 | 105,000 | SEC↗ |
| Muller Lorenz | Chief Commercial Officer | A Award deriv | 2023-02-16 | 2023-02-17 | 105,000 | — | $0 | 105,000 | SEC↗ |
| Bharucha David | Chief Medical Officer | P Buy | 2022-12-05 | 2022-12-05 | 7,000 | $4.69 | $32.8K | 10,000 | SEC↗ |
| Bharucha David | Chief Medical Officer | P Buy | 2022-12-01 | 2022-12-05 | 3,000 | $4.86 | $14.6K | 3,000 | SEC↗ |
| Liebert Debra K. | Director | P Buy | 2022-10-21 | 2022-10-21 | 4,000 | $5.26 | $21.0K | 4,000 | SEC↗ |
| Liebert Debra K. | Director | P Buy | 2022-10-20 | 2022-10-21 | 10,000 | $5.29 | $52.9K | 10,000 | SEC↗ |
| Pasternak Richard C | Director | P Buy | 2022-10-20 | 2022-10-21 | 10,000 | $5.20 | $52.0K | 10,000 | SEC↗ |
| TOMSICEK MICHAEL JOHN | Director | P Buy | 2022-10-19 | 2022-10-21 | 15,000 | $5.32 | $79.8K | 15,000 | SEC↗ |
| Wills Robert James | Director | P Buy | 2022-10-19 | 2022-10-21 | 15,000 | $4.93 | $74.0K | 15,000 | SEC↗ |
| Liebert Debra K. | Director | J Other | 2022-09-14 | 2022-09-15 | 127 | — | $0 | 127 | SEC↗ |
| RTW INVESTMENTS, LP | 10% Owner | S Sale | 2022-09-07 | 2022-09-09 | 1,557,346 | $8.71 | $13.56M | 4,315,102 | SEC↗ |
| RTW INVESTMENTS, LP | 10% Owner | P Buy | 2022-09-07 | 2022-09-09 | 1,557,346 | $8.71 | $13.56M | 4,315,102 | SEC↗ |
| Liebert Debra K. | Director | A Award deriv | 2022-07-05 | 2022-08-11 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Giles Lisa M. | Director | A Award deriv | 2022-07-05 | 2022-08-11 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Wills Robert James | Director | A Award deriv | 2022-07-05 | 2022-08-11 | 30,000 | — | $0 | 30,000 | SEC↗ |
| TOMSICEK MICHAEL JOHN | Director | A Award deriv | 2022-07-05 | 2022-08-11 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Pasternak Richard C | Director | A Award deriv | 2022-07-05 | 2022-08-11 | 30,000 | — | $0 | 30,000 | SEC↗ |
| TRUEX PAUL F | Director | M Exercise deriv | 2022-05-31 | 2022-06-01 | 822 | — | $0 | 117 | SEC↗ |
| TRUEX PAUL F | Director | M Exercise deriv | 2022-05-31 | 2022-06-01 | 45,072 | — | $0 | 0 | SEC↗ |
| TRUEX PAUL F | Director | M Exercise deriv | 2022-05-31 | 2022-06-01 | 8,016 | — | $0 | 0 | SEC↗ |
| TRUEX PAUL F | Director | M Exercise deriv | 2022-05-31 | 2022-06-01 | 22,870 | — | $0 | 2,659 | SEC↗ |
| TRUEX PAUL F | Director | M Exercise | 2022-05-31 | 2022-06-01 | 8,016 | $1.12 | $9.0K | 8,016 | SEC↗ |
| TRUEX PAUL F | Director | M Exercise | 2022-05-31 | 2022-06-01 | 45,072 | $1.54 | $69.4K | 53,088 | SEC↗ |
| TRUEX PAUL F | Director | M Exercise | 2022-05-31 | 2022-06-01 | 22,870 | $1.54 | $35.2K | 75,958 | SEC↗ |
| TRUEX PAUL F | Director | M Exercise | 2022-05-31 | 2022-06-01 | 822 | $2.66 | $2.2K | 76,780 | SEC↗ |
| TRUEX PAUL F | Director | P Buy | 2022-05-31 | 2022-06-01 | 5,000 | $5.60 | $28.0K | 81,780 | SEC↗ |
| Muller Lorenz | Chief Commercial Officer | A Award deriv | 2022-03-21 | 2022-03-23 | 160,000 | — | $0 | 160,000 | SEC↗ |
| Hasija Amit | CFO & EVP of Corp. Developme | A Award deriv | 2022-03-21 | 2022-03-23 | 175,000 | — | $0 | 175,000 | SEC↗ |
| Oliveto Joseph | President and CEO | A Award deriv | 2022-03-21 | 2022-03-23 | 500,000 | — | $0 | 500,000 | SEC↗ |
| Bharucha David | Chief Medical Officer | A Award deriv | 2022-02-15 | 2022-02-17 | 330,000 | — | $0 | 330,000 | SEC↗ |
| Wills Robert James | Director | A Award deriv | 2021-06-14 | 2021-07-29 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Giles Lisa M. | Director | A Award deriv | 2021-06-14 | 2021-07-29 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Liebert Debra K. | Director | A Award deriv | 2021-06-14 | 2021-07-29 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Pasternak Richard C | Director | A Award deriv | 2021-06-14 | 2021-07-29 | 30,000 | — | $0 | 30,000 | SEC↗ |
| TOMSICEK MICHAEL JOHN | Director | A Award deriv | 2021-06-14 | 2021-07-29 | 30,000 | — | $0 | 30,000 | SEC↗ |
| TRUEX PAUL F | Director | A Award deriv | 2021-06-14 | 2021-07-29 | 30,000 | — | $0 | 30,000 | SEC↗ |
| RTW INVESTMENTS, LP | 10% Owner | P Buy deriv | 2021-05-21 | 2021-05-24 | 910,746 | $5.48 | $4.99M | 8,518,257 | SEC↗ |
| Muller Lorenz | Chief Commercial Officer | A Award deriv | 2021-03-24 | 2021-03-26 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Hasija Amit | CFO & EVP of Corp. Developme | A Award deriv | 2021-03-24 | 2021-03-26 | 240,000 | — | $0 | 240,000 | SEC↗ |
| Plat Francis | Chief Medical Officer | A Award deriv | 2021-03-24 | 2021-03-26 | 130,000 | — | $0 | 130,000 | SEC↗ |
| Oliveto Joseph | President and CEO | A Award deriv | 2021-03-24 | 2021-03-26 | 670,000 | — | $0 | 670,000 | SEC↗ |
| RTW INVESTMENTS, LP | 10% Owner | P Buy deriv | 2020-10-27 | 2020-10-29 | 952,380 | $5.24 | $4.99M | 7,607,511 | SEC↗ |
| Giles Lisa M. | Director | A Award deriv | 2020-10-01 | 2020-10-05 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Wills Robert James | Director | A Award deriv | 2020-10-01 | 2020-10-05 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Muller Lorenz | Chief Commercial Officer | M Exercise deriv | 2020-08-26 | 2020-08-28 | 5,700 | — | $0 | 49,754 | SEC↗ |
| Muller Lorenz | Chief Commercial Officer | M Exercise | 2020-08-26 | 2020-08-28 | 5,700 | $1.54 | $8.8K | 108,386 | SEC↗ |
| FONDS DE SOLIDARITE DES TRAVAI | 10% Owner | S Sale | 2020-07-29 | 2020-07-30 | 500,000 | $8.32 | $4.16M | 2,254,920 | SEC↗ |
| FONDS DE SOLIDARITE DES TRAVAI | 10% Owner | S Sale | 2020-07-28 | 2020-07-30 | 19,863 | $8.10 | $160.9K | 2,754,920 | SEC↗ |
| RTW INVESTMENTS, LP | 10% Owner | P Buy deriv | 2020-07-22 | 2020-07-24 | 6,655,131 | $3.75 | $24.96M | 6,655,131 | SEC↗ |
| Muller Lorenz | Chief Commercial Officer | A Award deriv | 2020-06-05 | 2020-06-08 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Edick Paul R | Director | A Award deriv | 2020-06-05 | 2020-06-08 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Hasija Amit | CFO & EVP of Corp. Developme | A Award deriv | 2020-06-05 | 2020-06-08 | 115,000 | — | $0 | 115,000 | SEC↗ |
| Liebert Debra K. | Director | A Award deriv | 2020-06-05 | 2020-06-08 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Oliveto Joseph | President and CEO | A Award deriv | 2020-06-05 | 2020-06-08 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Pasternak Richard C | Director | A Award deriv | 2020-06-05 | 2020-06-08 | 15,000 | — | $0 | 15,000 | SEC↗ |
| TOMSICEK MICHAEL JOHN | Director | A Award deriv | 2020-06-05 | 2020-06-08 | 15,000 | — | $0 | 15,000 | SEC↗ |
| TRUEX PAUL F | Director | A Award deriv | 2020-06-05 | 2020-06-08 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Plat Francis | Chief Medical Officer | A Award deriv | 2020-06-05 | 2020-06-08 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Muller Lorenz | Chief Commercial Officer | M Exercise deriv | 2020-04-03 | 2020-06-08 | 18,043 | — | $0 | 32,903 | SEC↗ |
| Muller Lorenz | Chief Commercial Officer | M Exercise deriv | 2020-04-03 | 2020-06-08 | 32,528 | — | $0 | 55,454 | SEC↗ |
| Muller Lorenz | Chief Commercial Officer | M Exercise | 2020-04-03 | 2020-06-08 | 32,528 | $1.54 | $50.1K | 84,643 | SEC↗ |
| Muller Lorenz | Chief Commercial Officer | M Exercise | 2020-04-03 | 2020-06-08 | 18,043 | $1.54 | $27.8K | 102,686 | SEC↗ |
| RTW INVESTMENTS, LP | 10% Owner | P Buy | 2020-03-19 | 2020-03-19 | 5,870 | $10.87 | $63.8K | 4,315,102 | SEC↗ |
| RTW INVESTMENTS, LP | 10% Owner | P Buy | 2020-03-18 | 2020-03-19 | 2,705 | $10.36 | $28.0K | 4,309,232 | SEC↗ |
| RTW INVESTMENTS, LP | 10% Owner | P Buy | 2020-03-02 | 2020-03-19 | 78,263 | $18.95 | $1.48M | 4,306,527 | SEC↗ |
| Muller Lorenz | Chief Commercial Officer | A Award deriv | 2020-01-23 | 2020-01-24 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Hasija Amit | CFO & EVP of Corp. Developme | A Award deriv | 2020-01-23 | 2020-01-24 | 82,000 | — | $0 | 82,000 | SEC↗ |
| Oliveto Joseph | President and CEO | A Award deriv | 2020-01-23 | 2020-01-24 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Plat Francis | Chief Medical Officer | A Award deriv | 2020-01-23 | 2020-01-24 | 84,000 | — | $0 | 84,000 | SEC↗ |
| WONG RODERICK | 10% Owner | P Buy | 2020-01-13 | 2020-01-13 | 270,000 | $16.25 | $4.39M | 4,228,264 | SEC↗ |
| RTW INVESTMENTS, LP | 10% Owner | P Buy | 2019-12-31 | 2020-01-02 | 21,438 | $15.50 | $332.3K | 3,958,264 | SEC↗ |
| RTW INVESTMENTS, LP | 10% Owner | P Buy | 2019-12-30 | 2020-01-02 | 1,333 | $15.48 | $20.6K | 3,936,826 | SEC↗ |
| Oliveto Joseph | President and CEO | M Exercise deriv | 2019-12-21 | 2020-06-08 | 7,400 | — | $0 | 113,856 | SEC↗ |
| Oliveto Joseph | President and CEO | M Exercise | 2019-12-21 | 2020-06-08 | 7,400 | $1.54 | $11.4K | 280,555 | SEC↗ |
| Novo Holdings A/S | 10% Owner | S Sale | 2019-11-25 | 2019-11-27 | 240,000 | $16.00 | $3.84M | 2,434,470 | SEC↗ |
| RTW INVESTMENTS, LP | 10% Owner | P Buy | 2019-11-20 | 2019-11-22 | 400,000 | $16.00 | $6.40M | 3,935,493 | SEC↗ |
| Pasternak Richard C | Director | A Award deriv | 2019-11-12 | 2019-11-14 | 19,000 | — | $0 | 19,000 | SEC↗ |
| Liebert Debra K. | Director | A Award deriv | 2019-11-12 | 2019-11-14 | 19,000 | — | $0 | 19,000 | SEC↗ |
| TRUEX PAUL F | Director | A Award deriv | 2019-11-12 | 2019-11-14 | 4,000 | — | $0 | 4,000 | SEC↗ |
| WONG RODERICK | 10% Owner | P Buy | 2019-10-15 | 2019-10-15 | 1,100 | $18.00 | $19.8K | 3,535,493 | SEC↗ |
| WONG RODERICK | 10% Owner | P Buy | 2019-10-11 | 2019-10-15 | 4,208 | $17.30 | $72.8K | 3,534,393 | SEC↗ |
| WONG RODERICK | 10% Owner | P Buy | 2019-10-10 | 2019-10-15 | 179 | $16.00 | $2.9K | 3,530,185 | SEC↗ |
| RTW INVESTMENTS, LP | 10% Owner | P Buy | 2019-10-03 | 2019-10-03 | 1,908 | $18.31 | $34.9K | 3,530,006 | SEC↗ |
| Muller Lorenz | Chief Commercial Officer | M Exercise deriv | 2019-10-01 | 2020-06-08 | 2,500 | — | $0 | 87,982 | SEC↗ |
| Muller Lorenz | Chief Commercial Officer | M Exercise | 2019-10-01 | 2020-06-08 | 2,500 | $1.54 | $3.9K | 52,115 | SEC↗ |
| RTW INVESTMENTS, LP | 10% Owner | P Buy | 2019-10-01 | 2019-10-03 | 6,242 | $17.63 | $110.0K | 3,528,098 | SEC↗ |
| Hasija Amit | CFO & EVP of Corp. Developme | A Award deriv | 2019-09-09 | 2019-09-11 | 147,000 | — | $0 | 147,000 | SEC↗ |
| Maness Timothy | Chief Accounting Officer | A Award deriv | 2019-09-09 | 2019-09-11 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Novo Holdings A/S | 10% Owner | M Exercise deriv | 2019-05-13 | 2019-05-14 | 964,089 | — | $0 | 0 | SEC↗ |
| Novo Holdings A/S | 10% Owner | M Exercise deriv | 2019-05-13 | 2019-05-14 | 1,377,048 | — | $0 | 0 | SEC↗ |
| Douville Philippe | Chief Scientific Officer | C Conversion deriv | 2019-05-13 | 2019-05-14 | 4,124 | — | $0 | 0 | SEC↗ |
| FONDS DE SOLIDARITE DES TRAVAI | 10% Owner | C Conversion deriv | 2019-05-13 | 2019-05-15 | 574,292 | — | $0 | 0 | SEC↗ |
| FONDS DE SOLIDARITE DES TRAVAI | 10% Owner | C Conversion deriv | 2019-05-13 | 2019-05-15 | 139,849 | — | $0 | 0 | SEC↗ |
| FONDS DE SOLIDARITE DES TRAVAI | 10% Owner | C Conversion deriv | 2019-05-13 | 2019-05-15 | 798,974 | — | $0 | 0 | SEC↗ |
| FONDS DE SOLIDARITE DES TRAVAI | 10% Owner | C Conversion deriv | 2019-05-13 | 2019-05-15 | 437,203 | — | $0 | 0 | SEC↗ |
| FONDS DE SOLIDARITE DES TRAVAI | 10% Owner | C Conversion deriv | 2019-05-13 | 2019-05-15 | 306,092 | — | $0 | 0 | SEC↗ |
| Novo Holdings A/S | 10% Owner | P Buy | 2019-05-13 | 2019-05-14 | 333,333 | $15.00 | $5.00M | 2,674,470 | SEC↗ |
| Novo Holdings A/S | 10% Owner | M Exercise | 2019-05-13 | 2019-05-14 | 964,089 | — | $0 | 2,341,137 | SEC↗ |
| Novo Holdings A/S | 10% Owner | M Exercise | 2019-05-13 | 2019-05-14 | 1,377,048 | — | $0 | 1,377,048 | SEC↗ |
| Douville Philippe | Chief Scientific Officer | C Conversion | 2019-05-13 | 2019-05-14 | 4,124 | — | $0 | 43,392 | SEC↗ |
| FONDS DE SOLIDARITE DES TRAVAI | 10% Owner | C Conversion | 2019-05-13 | 2019-05-15 | 574,292 | — | $0 | 1,543,682 | SEC↗ |
| FONDS DE SOLIDARITE DES TRAVAI | 10% Owner | C Conversion | 2019-05-13 | 2019-05-15 | 798,974 | — | $0 | 969,390 | SEC↗ |
| FONDS DE SOLIDARITE DES TRAVAI | 10% Owner | C Conversion | 2019-05-13 | 2019-05-15 | 139,849 | — | $0 | 170,416 | SEC↗ |
| FONDS DE SOLIDARITE DES TRAVAI | 10% Owner | P Buy | 2019-05-13 | 2019-05-15 | 433,333 | $15.00 | $6.50M | 2,720,310 | SEC↗ |
| FONDS DE SOLIDARITE DES TRAVAI | 10% Owner | C Conversion | 2019-05-13 | 2019-05-15 | 437,203 | — | $0 | 1,980,885 | SEC↗ |
| FONDS DE SOLIDARITE DES TRAVAI | 10% Owner | C Conversion | 2019-05-13 | 2019-05-15 | 306,092 | — | $0 | 2,286,977 | SEC↗ |
| RTW INVESTMENTS, LP | 10% Owner | C Conversion deriv | 2019-05-09 | 2019-05-09 | 203,942 | — | $0 | 0 | SEC↗ |
| RTW INVESTMENTS, LP | 10% Owner | C Conversion deriv | 2019-05-09 | 2019-05-09 | 2,651,247 | — | $0 | 0 | SEC↗ |
| RTW INVESTMENTS, LP | 10% Owner | C Conversion | 2019-05-09 | 2019-05-09 | 2,651,247 | — | $0 | 2,651,247 | SEC↗ |
| RTW INVESTMENTS, LP | 10% Owner | P Buy | 2019-05-09 | 2019-05-09 | 666,667 | $15.00 | $10.00M | 3,521,856 | SEC↗ |
| RTW INVESTMENTS, LP | 10% Owner | C Conversion | 2019-05-09 | 2019-05-09 | 203,942 | — | $0 | 2,855,189 | SEC↗ |
| Maness Timothy | Vice President, Finance | A Award deriv | 2019-05-08 | 2019-05-09 | 46,998 | — | $0 | 46,998 | SEC↗ |
| BDC CAPITAL INC. | 10% Owner | P Buy | 2019-05-08 | 2019-05-09 | 200,000 | $15.00 | $3.00M | 2,388,088 | SEC↗ |